ES2190487T3 - Nuevos agonistas y antagonistas del receptor de adenosina a1. - Google Patents

Nuevos agonistas y antagonistas del receptor de adenosina a1.

Info

Publication number
ES2190487T3
ES2190487T3 ES96945316T ES96945316T ES2190487T3 ES 2190487 T3 ES2190487 T3 ES 2190487T3 ES 96945316 T ES96945316 T ES 96945316T ES 96945316 T ES96945316 T ES 96945316T ES 2190487 T3 ES2190487 T3 ES 2190487T3
Authority
ES
Spain
Prior art keywords
antagonists
new agonists
adenosine
receiver
adenosine receiver
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96945316T
Other languages
English (en)
Inventor
Luiz Belardinelli
Ray Olsson
Stephen Baker
Peter J Scammells
Peter G Milner
Jurg R Pfister
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Florida
University of Florida Research Foundation Inc
Original Assignee
University of Florida
University of Florida Research Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Florida, University of Florida Research Foundation Inc filed Critical University of Florida
Application granted granted Critical
Publication of ES2190487T3 publication Critical patent/ES2190487T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

Compuesto que tiene la estructura: **(Fórmula)**
ES96945316T 1995-12-29 1996-12-26 Nuevos agonistas y antagonistas del receptor de adenosina a1. Expired - Lifetime ES2190487T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/581,655 US5736528A (en) 1993-10-28 1995-12-29 N6 -(epoxynorborn-2-yl) adenosines as A1 adenosine receptor agonists

Publications (1)

Publication Number Publication Date
ES2190487T3 true ES2190487T3 (es) 2003-08-01

Family

ID=24326044

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96945316T Expired - Lifetime ES2190487T3 (es) 1995-12-29 1996-12-26 Nuevos agonistas y antagonistas del receptor de adenosina a1.

Country Status (15)

Country Link
US (2) US5736528A (es)
EP (1) EP1019426B1 (es)
JP (1) JP2000502712A (es)
KR (1) KR19990076916A (es)
CN (1) CN1163502C (es)
AT (1) ATE234322T1 (es)
AU (1) AU728439B2 (es)
BR (1) BR9612324A (es)
CA (1) CA2238736C (es)
DE (1) DE69626705T2 (es)
DK (1) DK1019426T3 (es)
ES (1) ES2190487T3 (es)
NZ (1) NZ326608A (es)
PT (1) PT1019426E (es)
WO (1) WO1997024363A1 (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5736528A (en) * 1993-10-28 1998-04-07 University Of Florida Research Foundation, Inc. N6 -(epoxynorborn-2-yl) adenosines as A1 adenosine receptor agonists
US5789416B1 (en) * 1996-08-27 1999-10-05 Cv Therapeutics Inc N6 mono heterocyclic substituted adenosine derivatives
US6790839B2 (en) 1999-01-07 2004-09-14 Can-Fite Biopharma Ltd. Pharmaceutical administration of adenosine agonists
IL127947A0 (en) * 1999-01-07 1999-11-30 Can Fite Technologies Ltd Pharmaceutical use of adenosine agonists
WO2001040799A2 (en) * 1999-12-03 2001-06-07 Cv Therapeutics, Inc. Method of identifying partial adenosine a1 receptor agonists and their use in the treatment of arrhythmias
US20030008841A1 (en) * 2000-08-30 2003-01-09 Rene Devos Anti-HCV nucleoside derivatives
RU2248208C2 (ru) * 2000-09-08 2005-03-20 Си Ви Терапьютикс, Инк. Пуринрибозиды в качестве антиаритмических средств
IL154652A0 (en) * 2000-09-08 2003-09-17 Cv Therapeutics Inc Purine ribosides as antiarrhythmics
CA2347879A1 (en) 2001-05-11 2002-11-11 Vanderbilt University Substituted dicinnamoylquinides and their use in augmentation of adenosine function
MXPA04010285A (es) * 2002-04-18 2005-02-03 Cv Therapeutics Inc Metodo para tratar arritmias que comprende la administracion de un agonista de adenosina a1 con un bloqueador beta, bloqueador del canal de calcio o un glucosido cardiaco.
US20040121406A1 (en) * 2002-05-23 2004-06-24 Wilson Constance Neely Methods and formulations for increasing the affinity of a1 adenosine receptor ligands for the a1 adenosine receptor
UA84404C2 (ru) * 2002-06-12 2008-10-27 Байоджен Айдек Ма Инк. Способ лечения ишемического реперфузионного повреждения с помощью антагонистов рецептора аденозина
US20040229901A1 (en) * 2003-02-24 2004-11-18 Lauren Otsuki Method of treatment of disease using an adenosine A1 receptor antagonist
EP1620107A1 (en) * 2003-04-25 2006-02-01 Novacardia, Inc. Method of improved diuresis in individuals with impaired renal function
EP1932529A1 (en) 2003-04-25 2008-06-18 Novacardia, Inc. Method of improved diuresis in individuals with impaired renal function
US20060293312A1 (en) * 2003-04-25 2006-12-28 Howard Dittrich Method of improved diuresis in individuals with impaired renal function
US20050239759A1 (en) * 2004-04-16 2005-10-27 Lauren Otsuki Method of treatment of disease using an adenosine A1 receptor antagonist and an aldosterone inhibitor
WO2006040765A1 (en) * 2004-10-12 2006-04-20 Closed Loop Therapies Ltd. Methods and implantable devices for treating supraventricular arrhythmias
ES2273599B1 (es) * 2005-10-14 2008-06-01 Universidad De Barcelona Compuestos para el tratamiento de la fibrilacion auricular.
JP2009540003A (ja) * 2006-06-16 2009-11-19 ノヴァカーディア，インク． Ａａ１ｒａの低頻度投与を含む腎機能の長期間にわたる改善
WO2008121893A1 (en) * 2007-03-29 2008-10-09 Novacardia, Inc. Methods of treating heart failure and renal dysfunction in individuals with an adenosine a1 receptor antagonist
WO2008121882A1 (en) * 2007-03-29 2008-10-09 Novacardia, Inc. Improved methods of administration of adenosine a1 receptor antagonists
DE102011005232A1 (de) 2011-03-08 2012-09-13 AristoCon GmbH & Co. KG Adenosin und seine Derivate zur Verwendung in der Schmerztherapie
TWI653227B (zh) * 2014-07-11 2019-03-11 Dow Agrosciences Llc 用於製備４－（１－（４－（全氟乙氧基）苯基）－１ｈ－１，２，４－三唑－３－基）苯甲醯疊氮化物之改良方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2460929A1 (de) * 1974-12-21 1976-06-24 Boehringer Sohn Ingelheim Neue xanthinderivate, verfahren zu ihrer herstellung und ihre anwendung
US4364922A (en) * 1980-10-14 1982-12-21 University Of Virginia Alumni Patents Foundation Adenosine antagonists in the treatment and diagnosis of A-V node conduction disturbances
DE3138397A1 (de) * 1981-09-26 1983-04-07 Hoechst Ag, 6230 Frankfurt "arzneimittel, darin enthaltene vicinale dihydroxyalkylxanthine und herstellungsverfahren fuer diese xanthinverbindungen"
US4980379A (en) * 1988-06-30 1990-12-25 The University Of Virginia Use of adenosine antagonists in the treatment of bradyarrhythmias and hemodynamic depression associated with cardiopulmonary resucitation and/or cardiovascular collapse
DE8817122U1 (de) * 1988-12-22 1993-02-04 Boehringer Ingelheim Kg, 55218 Ingelheim Neue Xanthinderivate mit Adenosinantogenistischer Wirkung
JPH06102662B2 (ja) * 1989-09-01 1994-12-14 協和醗酵工業株式会社 キサンチン誘導体
DE4019892A1 (de) * 1990-06-22 1992-01-02 Boehringer Ingelheim Kg Neue xanthinderivate
DE4205306B4 (de) * 1992-02-21 2005-11-24 Glüsenkamp, Karl-Heinz, Dr. Säureamide, Arzneimittel mit denselben und Verfahren zur Herstellung von Säureamiden
US5288721A (en) * 1992-09-22 1994-02-22 Cell Therapeutics, Inc. Substituted epoxyalkyl xanthines
WO1994016702A1 (fr) * 1993-01-26 1994-08-04 Kyowa Hakko Kogyo Co., Ltd. Medicament contre l'elimination irreguliere des matieres fecales
US5736528A (en) * 1993-10-28 1998-04-07 University Of Florida Research Foundation, Inc. N6 -(epoxynorborn-2-yl) adenosines as A1 adenosine receptor agonists
US5446046A (en) * 1993-10-28 1995-08-29 University Of Florida Research Foundation A1 adenosine receptor agonists and antagonists as diuretics

Also Published As

Publication number Publication date
JP2000502712A (ja) 2000-03-07
CN1206420A (zh) 1999-01-27
ATE234322T1 (de) 2003-03-15
AU728439B2 (en) 2001-01-11
BR9612324A (pt) 1999-12-28
AU1522097A (en) 1997-07-28
CA2238736A1 (en) 1997-07-10
DK1019426T3 (da) 2003-07-14
NZ326608A (en) 2000-04-28
WO1997024363A1 (en) 1997-07-10
DE69626705T2 (de) 2003-09-18
US5998387A (en) 1999-12-07
CN1163502C (zh) 2004-08-25
KR19990076916A (ko) 1999-10-25
EP1019426A1 (en) 2000-07-19
US5736528A (en) 1998-04-07
CA2238736C (en) 2003-09-16
PT1019426E (pt) 2003-07-31
DE69626705D1 (de) 2003-04-17
EP1019426B1 (en) 2003-03-12

Similar Documents

Publication Publication Date Title
ES2190487T3 (es) Nuevos agonistas y antagonistas del receptor de adenosina a1.
ES2195970T3 (es) L-ribavirina y usos de la misma.
TR199701146T1 (xx) N�rotensin resept�rleri �zerinde etkili 1-Fenilpirazol-3-Karboksamidler.
CR6478A (es) Moduladores del receptor glucocorticoide
ZA981936B (en) Novel benzimidazole inhibitors of fructose 1,6-bisphosphatase.
TR199801255T2 (xx) Vitronektin resept�r antagonistleri.
EA199900630A1 (ru) Антагонисты рецепторов витронектина
EA200101177A1 (ru) Производные индола в качестве антагонистов прогестерона
TR199600001A2 (tr) Estrojen agonistleri / antagonistleri.
ES2052704T3 (es) Analogos de benzodiacepina.
DE69815378D1 (de) Adenosin a1-rezeptor agonisten
DE69825780D1 (de) Adenosin a1-rezeptor agonisten
TR200000333T2 (tr) Y alıcı antagonistleri olarak 4-aminopirol (3,2-d) pirimidinler.
TR199801253T2 (xx) Vitronektin resept�r� antagonistleri.
ES2184797T3 (es) Uso de antagonistas de serotonina (5ht3) para el tratamiento de la fibromialgia.
BR0015985A (pt) Aplique, e, aeronave
DK0975327T3 (da) Anvendelse af 5HT3-antagonister til befordring af tarmudskylning
FI912621A0 (fi) Farmakologiskt aktiva foereningar med verkan pao det centrala nervsystemet.
EA200001039A1 (ru) Кальцилитические соединения
ES2171196T3 (es) Uso de antagonistas del receptor cck-b para el tratamiento de trastornos del sueño.
ES2060818T3 (es) Derivados de indol, benzofurano y benzotiofeno sustituidos como inhibidores de la 5-lipooxigenasa.
ATE198202T1 (de) Fibrinogen receptor antagonisten
ES2117654T3 (es) Antagonistas de colecistoquinina.
PT1200400E (pt) Derivados de pirrolidino-2,3,4-trion-3-oxina substituidas com eficacia como antagonistas do receptor nmda
IT1270612B (it) Derivati eterociclo-condensatori di morfinoidi